How Barts Life Sciences support clinical trials
Ahead of International Clinical Trials Day, we catch up with Gretchen Ladish, programme manager for Barts Life Sciences.
Research at Barts Health — articles for 2022
“To me, it’s fascinating and vital to the future of healthcare”
In the lead-up to International Clinical Trials Day, Sophie Williams, PhD, talks about her work as a data researcher.
New drug for aggressive breast cancer could save thousands of lives
An immunotherapy drug called ‘pembrolizumab’ has been shown to significantly reduce disease recurrence in patients with the most aggressive type of breast cancer, according to results from a phase III clinical trial led.